Compare BioNano Genomics Inc (BNGO) vs Suncor Energy Inc. (SU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Suncor Energy Inc. — how do they compare? BioNano Genomics Inc trades at $1.17 (market cap $13.66M), while Suncor Energy Inc. trades at $63.3 (market cap $74.07B). The key difference: Suncor Energy Inc. is far larger — about 5422.4× BioNano Genomics Inc's market cap, and Suncor Energy Inc. pays a 2.7% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | SU | |
|---|---|---|
Market Cap | $13.66M | $74.07B |
Sector | Health | Energy |
52-Week High | $4.92 | $69.73 |
52-Week Low | $1.06 | $38.17 |
Enterprise Value | $16.26M | $80.75B |
Dividend Yield | — | 2.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.16 with a bullish technical signal supported by moving averages. The company shows improving financial trends with narrowing losses and consistent earnings beats, though it remains unprofitable with negative margins. Recent news highlights operational progress including debt retirement and scientific publications. Valuation ratios appear attractive with P/S of 0.31 and P/B of 0.36.
The outlook remains speculative given persistent losses, but improving cash flow trends and analyst optimism provide catalysts. Key risks include ongoing negative profitability and competitive pressures in genomics. With 57% analyst buy ratings and bullish technical momentum, the stock offers high-risk growth potential for investors comfortable with biotech volatility.
Suncor Energy (SU) trades at $62.73, up 4.38% today, with a bearish technical signal but strong fundamentals including a P/E of 11.79 and net margin of 14.7%. Recent Q2 2026 earnings beat estimates at $2.27 EPS, driven by higher crude realizations and refining margins (Reuters, 2026-08-04). The company maintains a consistent dividend of $0.60 per share and announced a CEO transition to Peter Zebedee in 2027.
Outlook is supported by solid cash flow and buybacks, but risks include commodity price volatility and operational disruptions. Analyst consensus is strongly bullish with 74% buy ratings, targeting upside from efficient operations and debt reduction, though technical weakness near support at $61 may limit near-term gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
